Click here for slides on this topic


Dual PPAR agonist

Investigational compound with insulin-sensitizing and glucose-lowering effects, as well as metabolic and lipid effects.
The following content matched the glossary term: Dual PPAR agonist

Effect of aleglitazar on cardiovascular outcomes after acute coronary syndrome in patients with type 2 diabetes mellitus

Top

Lincoff AM, Tardiff J-C, Schwartz GG, et al; for the AleCardio Investigators. Effect of aleglitazar on cardiovascular outcomes after acute coronary syndrome in patients with type 2 diabetes mellitus. The AleCardio randomized clinical trial. JAMA.. 2014. doi:10.1001/jama.2014.3321.



Slide Library Results

Search Results for: Dual PPAR agonist Slides Found: 0